{
  "schema_version": "0.1.0",
  "case_id": "HR-ML021",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML021",
    "display_name": "Nelson Mandela",
    "aliases": [
      "Nelson Rolihlahla Mandela"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "South African",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1918-07-18",
          "display": "18 July 1918",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1918",
              "display": "1918",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0009"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Nelson Mandela Foundation biography."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2013-12-05",
          "display": "5 December 2013",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2013",
              "display": "2013",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0009"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Nelson Mandela Foundation biography."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML021-SYN",
      "ssn": "000-21-6718",
      "date_of_birth": "1943-07-18",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Thandiwe Mokoena, MD",
      "fictional_consultant": {
        "name": "Pieter van Zyl, MD",
        "specialty": "Radiation Oncology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1918-07-18",
        "display": "18 July 1918",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Mvezo, Eastern Cape.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1964-06-12",
        "display": "12 June 1964",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Sentenced to life imprisonment after the Rivonia Trial.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1985",
        "display": "1985",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Prostate surgery for an enlarged gland while imprisoned.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1988-08-12",
        "display": "12 August 1988",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Taken to hospital and diagnosed with tuberculosis.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1990-02-11",
        "display": "11 February 1990",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Released from Victor Verster Prison.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1994-05-10",
        "display": "10 May 1994",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Inaugurated as president of South Africa.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "2000-11",
        "display": "November 2000",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "A raised PSA level is found on routine monitoring; a later biopsy shows microscopic prostate cancer.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "2001-07-24",
        "display": "July 24, 2001",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Diagnosis announced; a seven-week course of curative radiotherapy begins after hormonal treatment.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "2001-08",
        "display": "August 2001",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "His office announces that radiation treatment will continue after a review of the options.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "2002",
        "display": "2002",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Announces that his doctors have cleared him of prostate cancer.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "2013-12-05",
        "display": "5 December 2013",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died at his home in Johannesburg.",
      "claim_ids": [
        "CLM-0010"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Nelson Rolihlahla Mandela was born in Mvezo, in the Eastern Cape, on 18 July 1918.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography, opening paragraph"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Mandela was convicted with seven co-accused in the Rivonia Trial on 11 June 1964 and sentenced to life imprisonment the next day. He was held on Robben Island, moved to Pollsmoor Prison on 31 March 1982 and to Victor Verster Prison near Paarl on 7 December 1988, and was released from Victor Verster on 11 February 1990.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography: imprisonment and release"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1985 Mandela had prostate surgery while imprisoned. His urologist said in July 2001 that the gland had been enlarged and was causing a urinary blockage, and that part of it was removed.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "An operation for benign prostatic enlargement long before the cancer; the type of operation was not made public. Reports differ on the year and on how much of the gland was removed.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography: prostate surgery in 1985"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Urologist's account of the earlier operation"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "context",
          "locator": "Gives the operation as 1990 and says most of the gland was removed"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Mandela was taken to hospital on 12 August 1988 and diagnosed with tuberculosis; public reports describe it as early tuberculosis, treated at the Constantiaberg Medi-clinic, after which he was moved to Victor Verster Prison.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Pulmonary tuberculosis treated in the past; recorded as personal history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography: 1988"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "1988 entry"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "His doctors said publicly in 2001 that he had been monitored regularly with the prostate-specific antigen (PSA) test, that a slight rise in the PSA led to a biopsy of the prostate, and that the biopsy confirmed microscopic cancer within the gland. News reports said the raised blood level was first found in November 2000.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "A PSA rise found on monitoring, with biopsy-proven localized prostate cancer. No PSA value, Gleason score, or stage was made public.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "'How was it diagnosed?'"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Associated Press, July 24, 2001"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "His spokeswoman said in July 2001 that the cancer was not of a high grade and should not shorten his life span. He received hormonal treatment (anti-androgens) for a while and then began a seven-week course of radiotherapy with curative intent, limited to the prostate, on July 24, 2001; no surgery or chemotherapy was needed. His urologist called it a very early cancer that should be cured.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Localized, not high-grade prostate cancer treated with hormone therapy and curative radiotherapy, as his doctors and spokeswoman described it.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "The Globe and Mail, July 25, 2001"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In August 2001 his office said he would continue radiation treatment after a review of the options by two physicians, a radiotherapist, and five urologists, who considered the size and grade of the tumour, the radiological tests, and his response to hormonal treatment; his office said his general health remained good.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The treatment decision as his office announced it.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "Mail & Guardian, August 18, 2001"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "In 2002 Mandela announced that his doctors had cleared him of prostate cancer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as he announced it; no later result was made public and none is used.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "2001 and 2002 entries"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "Mandela was inaugurated as South Africa's first democratically elected president on 10 May 1994 and stepped down in 1999 after one term.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography: presidency"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "Mandela died at his home in Johannesburg on 5 December 2013.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as a fact; no detail of his last years is used.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Biography, closing paragraph"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "5 December 2013 entry"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Biography of Nelson Mandela",
      "publisher": "Nelson Mandela Foundation",
      "url": "https://www.nelsonmandela.org/content/page/biography",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Foundation biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Early prostate cancer is curable (archived copy)",
      "publisher": "Health24",
      "url": "http://web.archive.org/web/20190716080120/https://www.health24.com/Medical/Prostate/Prostate-cancer-in-SA/Early-prostate-cancer-is-curable-20120721",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Health news article reporting his doctors' statements; facts used with citation. The original URL now redirects; the archived copy was read."
    },
    {
      "source_id": "SRC-0003",
      "title": "Former South African President Nelson Mandela diagnosed with prostate cancer (Associated Press)",
      "publisher": "News On 6",
      "url": "https://www.newson6.com/story/5e36817c2f69d76f62095cfe/former-south-african-president-nelson-mandela-diagnosed-with-prostate-cancer",
      "source_type": "other",
      "published": "2001-07-24",
      "accessed": "2026-11-03",
      "rights_note": "News report; facts and short quotations of his spokeswoman and urologist used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Mandela begins radiation therapy",
      "publisher": "Irish Examiner",
      "url": "https://www.irishexaminer.com/world/arid-30019080.html",
      "source_type": "other",
      "published": "2001-07-24",
      "accessed": "2026-11-03",
      "rights_note": "News report; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Mandela's prostate cancer not terminal, doctor says",
      "publisher": "The Globe and Mail",
      "url": "https://www.theglobeandmail.com/news/world/mandelas-prostate-cancer-not-terminal-doctor-says/article1032487",
      "source_type": "other",
      "published": "2001-07-25",
      "accessed": "2026-11-03",
      "rights_note": "News report; facts and short quotations of his spokeswoman and urologist used with citation. Statements by other public figures in the report are not used."
    },
    {
      "source_id": "SRC-0006",
      "title": "Mandela to continue radiation treatment",
      "publisher": "Mail & Guardian",
      "url": "https://mg.co.za/article/2001-08-18-mandela-to-continue-radiation-treatment/",
      "source_type": "other",
      "published": "2001-08-18",
      "accessed": "2026-11-03",
      "rights_note": "News report of his office's statement; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Illnesses Madiba has suffered",
      "publisher": "SABC News",
      "url": "https://www.sabcnews.com/sabcnews/illnesses-madiba-has-suffered/",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Public broadcaster's timeline; used only for the 1988 tuberculosis and the 2001 and 2002 prostate cancer entries."
    },
    {
      "source_id": "SRC-0008",
      "title": "Nelson Mandela timeline 2000-2014",
      "publisher": "South African History Online",
      "url": "https://www.sahistory.org.za/article/nelson-mandela-timeline-2000-2014",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Timeline; facts used with citation."
    },
    {
      "source_id": "SRC-0009",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-03",
      "accessed": "2026-11-03",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-10",
    "index_age": 82,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Localized prostate cancer found by a rising PSA in a fit man of 82, on the NCCN prostate guideline, the AUA/ASTRO 2022 localized prostate cancer guideline, and the CMID prostate cancer monograph: risk grouping and staging (unfavorable intermediate risk, with PSMA PET); shared decision-making among observation, radiotherapy with short-term androgen deprivation, and surgery, with life expectancy and an earlier prostate operation weighed; six months of androgen deprivation with radiotherapy, and the monitoring it needs (testosterone, bone density and vitamin D, glucose and lipids, blood pressure, hot flashes, mood, and cognition); urinary and bowel effects of radiotherapy; and PSA surveillance after radiotherapy with the Phoenix definition of recurrence. His doctors' public account, a slight PSA rise on monitoring, a biopsy, hormone therapy, and a seven-week course of curative radiotherapy, frames the episode.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-10",
        "purpose": "First visit after a biopsy diagnosis of localized prostate cancer: risk group, staging, baseline before treatment, and radiation oncology referral"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-04-14",
        "purpose": "Five-week follow-up with radiation oncology consultation: staging result, shared decision on treatment, start of androgen deprivation, and bone density"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-06-09",
        "purpose": "Subsequent annual wellness visit"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-07-14",
        "purpose": "Three-month follow-up on androgen deprivation before radiotherapy: PSA, testosterone, vitamin D, and side effects"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-10-27",
        "purpose": "Follow-up six weeks after radiotherapy: PSA, urinary and bowel effects, end of androgen deprivation, and the surveillance plan"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Adenocarcinoma of the prostate, NCCN unfavorable intermediate risk: cT1c, Grade Group 3 (Gleason 4+3), PSA 6.4 ng/mL, 3 of 14 cores, found after a rising PSA; synthetic modern detail linked to his publicly announced prostate cancer",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C61",
            "display": "Malignant neoplasm of prostate",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic grade, PSA, core count, stage, and risk group; the PSA rise, the biopsy-proven localized cancer that was not high grade, hormone therapy, and curative radiotherapy are from his doctors' and spokeswoman's public statements (D).",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Hormone-sensitive prostate cancer",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z19.1",
            "display": "Hormone sensitive malignancy status",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic status in the modern episode.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-003",
        "display": "Short-term androgen deprivation therapy (six months, leuprolide), with monitoring of testosterone, bone density, metabolic and cardiovascular risk, hot flashes, mood, and cognition",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.899",
            "display": "Other long term (current) drug therapy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic androgen deprivation plan; Z79.899 is used because ICD-10-CM has no specific code for GnRH agonist therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-14"
      },
      {
        "id": "PRB-004",
        "display": "History of pulmonary tuberculosis, treated, with no symptoms since",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z86.11",
            "display": "Personal history of tuberculosis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "The 1988 tuberculosis is documented (D); the coding and the statement that it has not recurred are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "historical"
      },
      {
        "id": "PRB-005",
        "display": "Personal history of external beam radiotherapy to the prostate",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z92.3",
            "display": "Personal history of irradiation",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic: recorded after the course of radiotherapy finished.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-10-27"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Bicalutamide 50 mg oral tablet, one tablet by mouth once daily for four weeks, to block the testosterone flare at the start of leuprolide",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199123",
            "display": "bicalutamide 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet once daily for four weeks"
        },
        "start_date": "2026-04-14",
        "end_date": "2026-05-12",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic anti-androgen started one week before the first leuprolide injection; his doctors said publicly that he received anti-androgens before radiotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Leuprolide acetate 22.5 mg injection (three-month depot), intramuscular, two doses twelve weeks apart (the second given at a primary care visit), about six months of androgen deprivation with radiotherapy",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2606516",
            "display": "leuprolide acetate 22.5 MG Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "intramuscular",
        "frequency": {
          "period": 12,
          "period_unit": "wk",
          "text": "One injection every twelve weeks, two doses"
        },
        "start_date": "2026-04-21",
        "end_date": "2026-10-06",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic short-term androgen deprivation with radiotherapy for unfavorable intermediate-risk disease; his hormonal treatment was described publicly only as hormonal treatment and anti-androgens.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet once daily"
        },
        "start_date": "2026-04-14",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D repletion for mild insufficiency and low bone mass before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Tamsulosin 0.4 mg oral capsule, one capsule by mouth once daily after the evening meal, for urinary frequency during radiotherapy",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "863669",
            "display": "tamsulosin hydrochloride 0.4 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One capsule once daily in the evening"
        },
        "start_date": "2026-08-18",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alpha-blocker started by radiation oncology in the fourth week of radiotherapy for urinary frequency and a weak stream.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-PSA-V1",
        "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
        "label": "PSA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 6.4,
        "unit": "ng/mL",
        "reference_range": {
          "high": 4.0
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2857-1",
            "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic PSA confirming the rise that led to biopsy; his doctors said publicly only that there was a slight rise, and no value was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V1",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 412,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916,
          "text": "264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal baseline testosterone before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 14.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal blood count at baseline; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 5.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal blood count at baseline; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 226,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal blood count at baseline; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Fasting glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 1.08,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 69,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 9.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 74,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal chemistry at baseline; normal alkaline phosphatase.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 5.5,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal metabolic baseline before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 184,
        "unit": "mg/dL",
        "reference_range": {
          "high": 200
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid baseline before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 52,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid baseline before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 112,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid baseline before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 98,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid baseline before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V1",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-10",
        "value": 26,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mild vitamin D insufficiency found at the bone-health baseline, common at his age.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-10",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic minimal depressive symptoms at the distress screen at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-IPSS-V1",
        "display": "International Prostate Symptom Score [IPSS]",
        "label": "IPSS total (0 to 35)",
        "status": "final",
        "effective_date": "2026-03-10",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "80976-4",
            "display": "International Prostate Symptom Score [IPSS]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic mild urinary symptoms at baseline, decades after an operation on the prostate.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-DXAFEM-V2",
        "display": "DXA Femur [T-score] Bone density",
        "label": "Femoral neck T-score (DXA)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-04-14",
        "value": -1.4,
        "unit": "{T-score}",
        "reference_range": {
          "low": -1.0,
          "text": "-1.0 or higher is normal; -2.5 or lower is osteoporosis"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "38263-0",
            "display": "DXA Femur [T-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic low bone mass at the femoral neck, typical for a man of 82, before androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-DXASPINE-V2",
        "display": "DXA Lumbar spine [T-score] Bone density",
        "label": "Lumbar spine T-score (DXA)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-04-14",
        "value": -0.6,
        "unit": "{T-score}",
        "reference_range": {
          "low": -1.0,
          "text": "-1.0 or higher is normal; -2.5 or lower is osteoporosis"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "38267-1",
            "display": "DXA Lumbar spine [T-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal lumbar spine bone density.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V2",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-04-14",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PSA-V3",
        "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
        "label": "PSA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 0.9,
        "unit": "ng/mL",
        "reference_range": {
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2857-1",
            "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic expected fall in PSA on androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V3",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 18,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916,
          "text": "264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic castrate testosterone on leuprolide (target below 50 ng/dL).",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V3",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-14",
        "value": 34,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D level after three months of cholecalciferol 1000 units a day.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V3",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-07-14",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen on androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PSA-V4",
        "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
        "label": "PSA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 0.4,
        "unit": "ng/mL",
        "reference_range": {
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2857-1",
            "display": "Prostate specific Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic falling PSA six weeks after radiotherapy; the nadir comes later.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V4",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Total testosterone",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 38,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916,
          "text": "264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic testosterone still suppressed three weeks after the second twelve-week depot ran out; recovery takes months at his age.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-IPSS-V4",
        "display": "International Prostate Symptom Score [IPSS]",
        "label": "IPSS total (0 to 35)",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 12,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "80976-4",
            "display": "International Prostate Symptom Score [IPSS]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate urinary symptoms six weeks after radiotherapy, improving on tamsulosin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V4",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V5",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-06-09",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen at the annual wellness visit, seven weeks into androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      },
      {
        "id": "OBS-MINICOG-V5",
        "display": "Total score [Mini-Cog]",
        "label": "Mini-Cog",
        "status": "final",
        "effective_date": "2026-06-09",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72233-0",
            "display": "Total score [Mini-Cog]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal cognitive screen at the annual wellness visit, also the cognition check on androgen deprivation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V5",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-06-09",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Multiparametric MRI of the prostate: gland volume 28 mL with a resection defect from the earlier operation; 9 mm PI-RADS 4 lesion in the left peripheral zone at the mid-gland; no extraprostatic extension, seminal vesicle invasion, or enlarged pelvic nodes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "719178004",
            "display": "Multiparametric MRI of prostate",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-01-20",
          "end": "2026-01-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic findings; his doctors said publicly that a PSA rise led to a biopsy, and the imaging was not described.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "MRI-ultrasound fusion transperineal biopsy of the prostate, at the urology practice: adenocarcinoma, Gleason 4+3 (Grade Group 3) in 1 of 2 targeted cores (30 percent of the core) and in 2 of 12 systematic cores (Gleason 3+4, 10 and 15 percent); 3 of 14 cores in all; no perineural invasion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "788708005",
            "display": "MRI-US fusion guided transperineal biopsy of prostate",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-02-10",
          "end": "2026-02-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic pathology; his doctors said publicly that a biopsy confirmed microscopic cancer within the prostate and that it was not of a high grade.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Gallium-68 PSMA PET/CT for staging: uptake only in the left peripheral zone of the prostate; no nodal, bone, or visceral disease (N0 M0)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "764820005",
            "display": "Positron emission tomography with computed tomography of whole body using gallium-68",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-03-31",
          "end": "2026-03-31"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic staging; radiological tests were mentioned publicly but not described.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Transperineal insertion of three gold fiducial markers into the prostate for image guidance, with planning CT and MRI",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1145042007",
            "display": "Ultrasonography guided transperineal insertion of fiducial marker into prostate using transrectal ultrasonographic guidance",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-07-07",
          "end": "2026-07-07"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic radiotherapy planning step.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Image-guided intensity-modulated radiotherapy to the prostate and proximal seminal vesicles, 74 Gy in 37 daily fractions over about seven and a half weeks, with curative intent; no pelvic nodal radiation",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "441799006",
            "display": "Intensity modulated radiation therapy",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-07-24",
          "end": "2026-09-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic technique, dose, and fractionation; the start date and the course of about seven weeks with curative intent, limited to the prostate, follow his doctors' public account.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-06-09",
          "end": "2026-06-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the annual wellness visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "High-dose influenza vaccine, last season",
        "status": "completed",
        "date": "2025-10-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "135",
            "display": "Influenza, high-dose, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2019-05-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "High-dose influenza vaccine, this season",
        "status": "completed",
        "date": "2026-10-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "135",
            "display": "Influenza, high-dose, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination at 65 or older, given at the follow-up visit after radiotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-06-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose recommended for adults 50 and older with no earlier conjugate vaccine.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-06-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose of the two-dose series recommended at 50 and older.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Operation on the prostate for an enlarged gland causing urinary blockage, with part of the gland removed (type of operation not recorded in the cited sources)",
        "historical_date": {
          "iso": "1985",
          "display": "1985",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Tuberculosis, diagnosed after admission to hospital and treated",
        "historical_date": {
          "iso": "1988-08-12",
          "display": "12 August 1988",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Raised PSA found on routine monitoring, followed by a prostate biopsy",
        "historical_date": {
          "iso": "2000-11",
          "display": "November 2000",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "First visit after a biopsy diagnosis of localized prostate cancer: risk group, staging, baseline before treatment, and radiation oncology referral",
        "status": "finished",
        "date": "2026-03-10",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Five-week follow-up with radiation oncology consultation: staging result, shared decision on treatment, start of androgen deprivation, and bone density",
        "status": "finished",
        "date": "2026-04-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Five-week follow-up after the prostate cancer diagnosis; staging result; radiation oncology seen today",
          "hpi": {
            "narrative": "Mr. Mandela returns five weeks after his first visit. The PSMA PET/CT two weeks ago showed uptake only in the prostate, with no spread to lymph nodes or bone. He had his DXA scan this morning and then saw Dr. van Zyl of radiation oncology, who went through observation, radiotherapy with short-term androgen deprivation, and surgery with him. He chose radiotherapy to the prostate with six months of androgen deprivation. He starts bicalutamide today and will have his first leuprolide injection at the radiation oncology clinic in one week. Before starting, he was told the expected effects of androgen deprivation (hot flashes, tiredness, loss of libido and erections, weight gain, bone loss, and changes in mood or memory) and how they are monitored. His urinary symptoms are unchanged and mild. He has no bone pain, weight loss, or breathlessness. He starts vitamin D today for the low level found at the first visit.",
            "elements": [
              {
                "label": "Staging",
                "value": "PSMA PET/CT: disease confined to the prostate (N0 M0)"
              },
              {
                "label": "Decision",
                "value": "Radiotherapy with six months of androgen deprivation, after radiation oncology consultation today"
              },
              {
                "label": "Starting today",
                "value": "Bicalutamide 50 mg daily for four weeks; cholecalciferol 1000 units daily"
              },
              {
                "label": "Next step",
                "value": "First leuprolide injection in one week at radiation oncology"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fatigue, weight loss, or night sweats"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Mild urinary frequency, unchanged; no blood in the urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No bone or back pain"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 130/76 mm Hg; no ankle swelling"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; bladder not palpable"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No spinal tenderness"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Prostate cancer, unfavorable intermediate risk, cT1c N0 M0",
              "assessment": "Staging is complete and shows localized disease. The decision for radiotherapy with six months of androgen deprivation follows the radiation oncology consultation and the guidelines for unfavorable intermediate risk in a fit man of his age",
              "plan": [
                "Bicalutamide 50 mg daily for four weeks from today",
                "Leuprolide 22.5 mg in one week, then every twelve weeks for a second dose",
                "Fiducial markers and planning scans in about twelve weeks; radiotherapy to start about three months after leuprolide"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Androgen deprivation therapy: baseline",
              "assessment": "Baseline testosterone 412 ng/dL, hemoglobin A1c 5.5 percent, LDL 112 mg/dL, and blood pressure 130/76 mm Hg. DXA shows low bone mass at the femoral neck (T-score -1.4) with a normal spine (-0.6). His ten-year hip fracture risk is below the 3 percent treatment threshold, so no bone drug is needed now. Vitamin D was 26 ng/mL",
              "plan": [
                "Cholecalciferol 1000 units daily from today",
                "Calcium from food, about 1000 to 1200 mg a day; walking and resistance exercise",
                "PSA, testosterone, and vitamin D in three months; DXA again in one to two years"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "PSA before treatment",
              "cadence": "At diagnosis, then every 3 to 6 months on androgen deprivation",
              "status": "up_to_date",
              "detail": "6.4 ng/mL at the first visit; next on androgen deprivation in three months",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-I",
                "GL-NCCN-PROSTATE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone",
              "cadence": "Baseline, then every 3 to 6 months on androgen deprivation (target below 50 ng/dL)",
              "status": "up_to_date",
              "detail": "412 ng/dL at the first visit, before treatment; recheck in three months",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c or fasting glucose, and lipid panel",
              "cadence": "Baseline and yearly on androgen deprivation",
              "status": "up_to_date",
              "detail": "A1c 5.5 percent, glucose 94 mg/dL, LDL 112 mg/dL at the first visit; next in one year",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium and 25-hydroxyvitamin D",
              "cadence": "Baseline and periodically on androgen deprivation",
              "status": "due",
              "detail": "Calcium 9.4 mg/dL and vitamin D 26 ng/mL at the first visit; supplement starts today; vitamin D recheck in three months",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Baseline before androgen deprivation, then every 1 to 2 years",
              "status": "completed_today",
              "detail": "Femoral neck T-score -1.4 (low bone mass); lumbar spine -0.6 (normal); hip fracture risk below the treatment threshold",
              "observation_ids": [
                "OBS-DXAFEM-V2",
                "OBS-DXASPINE-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "PSMA PET/CT staging",
              "cadence": "Once, for unfavorable intermediate or high risk",
              "status": "up_to_date",
              "detail": "Two weeks ago: no nodal, bone, or visceral disease",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-I",
                "GL-NCCN-PROSTATE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure and cardiovascular assessment",
              "cadence": "Every visit on androgen deprivation",
              "status": "completed_today",
              "detail": "130/76 mm Hg; no chest pain or breathlessness; baseline before treatment",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-2)",
              "cadence": "At diagnosis and at intervals",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "observation_ids": [
                "OBS-PHQ2-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Urinary symptoms (IPSS)",
              "cadence": "Baseline before treatment, then every follow-up visit",
              "status": "up_to_date",
              "detail": "IPSS 7 (mild) at the first visit; no change today",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Sexual function",
              "cadence": "Baseline before treatment and periodically",
              "status": "completed_today",
              "detail": "Reviewed before androgen deprivation; the expected effects were explained",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognition",
              "cadence": "Periodically on androgen deprivation",
              "status": "due",
              "detail": "Cognitive screen at the annual wellness visit in about eight weeks",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hot flashes and fatigue",
              "cadence": "Every visit on androgen deprivation",
              "status": "not_indicated",
              "detail": "Androgen deprivation not yet started; counseled on what to expect",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Testosterone flare protection",
              "cadence": "When starting a GnRH agonist",
              "status": "completed_today",
              "detail": "Bicalutamide starts today, one week before leuprolide, and continues for four weeks",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-I",
                "GL-NCCN-PROSTATE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Radiation oncology",
              "cadence": "Once, then through treatment",
              "status": "completed_today",
              "detail": "Seen today; recommendations in the consultation note",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-I",
                "GL-NCCN-PROSTATE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Physical activity, calcium intake, and no tobacco",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Walking every morning; resistance exercise added; dietary calcium reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            }
          ],
          "follow_up": "Leuprolide at radiation oncology in one week. Annual wellness visit in eight weeks. Primary care follow-up in three months with PSA, testosterone, and vitamin D",
          "guideline_ids": [
            "GL-NCCN-PROSTATE-2026",
            "GL-AUA-ASTRO-PCA-2022-I",
            "GL-ACS-PCA-SURV-2014",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Three-month follow-up on androgen deprivation before radiotherapy: PSA, testosterone, vitamin D, and side effects",
        "status": "finished",
        "date": "2026-07-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Three-month follow-up on androgen deprivation, ten days before radiotherapy",
          "hpi": {
            "narrative": "Mr. Mandela returns three months after his last visit, twelve weeks after his first leuprolide injection. He completed four weeks of bicalutamide. Hot flashes continue three or four times a week and are mild; his energy is a little lower in the afternoons, and he still walks every morning. His weight is up 1.2 kg since starting treatment. He has had no breast tenderness, chest pain, breathlessness, or leg swelling, and his mood and memory are unchanged. Fiducial markers were placed and the planning scans done a week ago, without complications. Radiotherapy starts in ten days. Urinary symptoms are unchanged. The audiology test after his wellness visit showed mild high-frequency hearing loss on the left, and he is thinking about a hearing aid. He takes vitamin D every day.",
            "elements": [
              {
                "label": "Androgen deprivation",
                "value": "Twelve weeks on leuprolide; second injection given today"
              },
              {
                "label": "Side effects",
                "value": "Mild hot flashes; slightly lower afternoon energy; weight up 1.2 kg"
              },
              {
                "label": "Radiotherapy",
                "value": "Fiducial markers placed and planning done; treatment starts in ten days"
              },
              {
                "label": "Hearing",
                "value": "Mild high-frequency loss on the left on audiology"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Slightly lower afternoon energy; weight up 1.2 kg"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Mild hot flashes three or four times a week; no breast tenderness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Mild urinary frequency, unchanged; no blood in the urine"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 1; no change in memory"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 134/78 mm Hg; no ankle swelling"
            },
            {
              "system": "Chest",
              "finding": "No gynecomastia"
            },
            {
              "system": "Perineum",
              "finding": "Fiducial insertion sites healed"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Prostate cancer, unfavorable intermediate risk, on androgen deprivation before radiotherapy",
              "assessment": "PSA has fallen from 6.4 to 0.9 ng/mL on androgen deprivation, as expected",
              "plan": [
                "Radiotherapy, 74 Gy in 37 fractions, starts in ten days",
                "Report urinary burning, frequency, or bowel urgency during treatment to radiation oncology"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Androgen deprivation therapy",
              "assessment": "Testosterone 18 ng/dL, at the castrate target. Mild hot flashes and fatigue; weight up 1.2 kg; blood pressure 134/78 mm Hg. Vitamin D is now 34 ng/mL",
              "plan": [
                "Second leuprolide 22.5 mg injection given today; this completes the six-month course",
                "Continue cholecalciferol 1000 units daily",
                "Keep walking and resistance exercise for fatigue, weight, and bone"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "PSA on androgen deprivation",
              "cadence": "Every 3 to 6 months",
              "status": "completed_today",
              "detail": "0.9 ng/mL, down from 6.4",
              "observation_ids": [
                "OBS-PSA-V3"
              ],
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-I",
                "GL-NCCN-PROSTATE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone",
              "cadence": "Every 3 to 6 months on androgen deprivation (target below 50 ng/dL)",
              "status": "completed_today",
              "detail": "18 ng/dL, castrate",
              "observation_ids": [
                "OBS-TESTO-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "Three months after starting a supplement",
              "status": "completed_today",
              "detail": "34 ng/mL, up from 26",
              "observation_ids": [
                "OBS-VITD-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c or fasting glucose, and lipid panel",
              "cadence": "Baseline and yearly on androgen deprivation",
              "status": "up_to_date",
              "detail": "Baseline four months ago; next in eight months",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Every 1 to 2 years on androgen deprivation",
              "status": "up_to_date",
              "detail": "Baseline three months ago",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight, and cardiovascular assessment",
              "cadence": "Every visit on androgen deprivation",
              "status": "completed_today",
              "detail": "134/78 mm Hg; weight 81.6 kg, up 1.2 kg since starting; no cardiac symptoms",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hot flashes and fatigue",
              "cadence": "Every visit on androgen deprivation",
              "status": "completed_today",
              "detail": "Mild hot flashes three or four times a week; mild afternoon fatigue; no treatment wanted",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-2)",
              "cadence": "At intervals",
              "status": "completed_today",
              "detail": "PHQ-2 score 1",
              "observation_ids": [
                "OBS-PHQ2-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognition",
              "cadence": "Periodically on androgen deprivation",
              "status": "up_to_date",
              "detail": "Mini-Cog 5 of 5 at the wellness visit five weeks ago; no change reported",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Urinary symptoms",
              "cadence": "Before radiotherapy, then every follow-up visit",
              "status": "completed_today",
              "detail": "Mild frequency, unchanged from the baseline IPSS of 7",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Bowel function before radiotherapy",
              "cadence": "Baseline before radiotherapy, then every visit after it",
              "status": "deferred",
              "detail": "Not asked today, a deviation from the protocol; the visit was taken up by the androgen deprivation results and the radiotherapy plan. To be checked at the next visit",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-III",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Second leuprolide injection",
              "cadence": "Every twelve weeks for two doses",
              "status": "completed_today",
              "detail": "Given today in this clinic",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Physical activity and calcium intake",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Walking every morning; resistance exercise twice a week; calcium from food",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            }
          ],
          "follow_up": "Radiotherapy from ten days' time, with weekly radiation oncology review. Primary care follow-up six weeks after radiotherapy ends, with PSA and testosterone",
          "guideline_ids": [
            "GL-NCCN-PROSTATE-2026",
            "GL-AUA-ASTRO-PCA-2022-III",
            "GL-ACS-PCA-SURV-2014",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Follow-up six weeks after radiotherapy: PSA, urinary and bowel effects, end of androgen deprivation, and the surveillance plan",
        "status": "finished",
        "date": "2026-10-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Follow-up six weeks after radiotherapy for prostate cancer",
          "hpi": {
            "narrative": "Mr. Mandela returns six weeks after finishing 37 fractions of radiotherapy, which he completed without a break. In the fourth week he developed urinary frequency, a weaker stream, and getting up twice a night, and radiation oncology started tamsulosin 0.4 mg in the evening; these symptoms are now improving, and he has had no burning, blood in the urine, or retention, and no dizziness on standing. In the last weeks of treatment his bowels became looser, two or three times a day with some urgency, and they are now settling to once or twice a day, with no bleeding. Asked about his bowels before treatment, he says they were regular, about once a day, as recorded at his wellness visit. His second leuprolide depot ran out about three weeks ago; hot flashes are fewer, and the tiredness he had during radiotherapy is lifting. His mood is good. He has resumed his morning walks.",
            "elements": [
              {
                "label": "Radiotherapy",
                "value": "74 Gy in 37 fractions, completed six weeks ago"
              },
              {
                "label": "Urinary",
                "value": "Frequency and nocturia twice, improving on tamsulosin; no blood or burning"
              },
              {
                "label": "Bowel",
                "value": "Looser stools and mild urgency, settling; no bleeding"
              },
              {
                "label": "Androgen deprivation",
                "value": "Completed; last depot ran out three weeks ago; hot flashes fading"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tiredness from radiotherapy, improving; weight stable"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Frequency and nocturia twice, improving; no burning, blood, or retention"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Stools once or twice a day, softer than before, with mild urgency; no bleeding"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Occasional hot flashes, fewer than before"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness on standing"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 128/74 mm Hg seated; no ankle swelling"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; bladder not palpable"
            },
            {
              "system": "Skin",
              "finding": "Mild hyperpigmentation over the treated area only; skin intact"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Prostate cancer, unfavorable intermediate risk, after radiotherapy with androgen deprivation",
              "assessment": "PSA 0.4 ng/mL six weeks after radiotherapy and three weeks after the end of androgen deprivation. The PSA nadir is usually reached over one to two years; a small temporary rise (a bounce) can occur and is not recurrence. Recurrence after radiotherapy is defined as a PSA rise of 2 ng/mL above the nadir (Phoenix)",
              "plan": [
                "PSA every six months for five years, then yearly",
                "Written survivorship care plan given today, with the surveillance schedule and symptoms to report"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "After external beam radiotherapy",
              "assessment": "Grade 1 urinary and bowel effects of radiotherapy, both improving. IPSS 12, up from 7 before treatment",
              "plan": [
                "Continue tamsulosin 0.4 mg in the evening; review at the next visit, with a view to stopping it once symptoms settle",
                "Report blood in the urine or rectal bleeding at any time, which would need urology or gastroenterology assessment"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Androgen deprivation therapy: completed",
              "assessment": "Testosterone 38 ng/dL, still low; it recovers slowly over months at his age, and hot flashes, fatigue, and weight should improve as it does",
              "plan": [
                "Testosterone with the next PSA",
                "Lipid panel and A1c at one year; DXA again in one to two years",
                "Continue cholecalciferol 1000 units daily and resistance exercise"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "PSA after radiotherapy",
              "cadence": "Every 6 to 12 months for 5 years, then yearly",
              "status": "completed_today",
              "detail": "0.4 ng/mL, first value after radiotherapy; next in six months",
              "observation_ids": [
                "OBS-PSA-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014",
                "GL-NCCN-PROSTATE-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Testosterone recovery",
              "cadence": "With PSA after androgen deprivation ends",
              "status": "completed_today",
              "detail": "38 ng/dL, not yet recovered",
              "observation_ids": [
                "OBS-TESTO-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c or fasting glucose, and lipid panel",
              "cadence": "Yearly after androgen deprivation",
              "status": "due",
              "detail": "Due in four months, one year after baseline",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Every 1 to 2 years after androgen deprivation",
              "status": "up_to_date",
              "detail": "Baseline six months ago; next in one to two years",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Digital rectal examination",
              "cadence": "Yearly after curative treatment",
              "status": "due",
              "detail": "Not useful this soon after radiotherapy; due in one year",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure and cardiovascular assessment",
              "cadence": "Every visit while on androgen deprivation and after",
              "status": "completed_today",
              "detail": "128/74 mm Hg seated; no dizziness on standing on tamsulosin",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Urinary symptoms (IPSS)",
              "cadence": "Every follow-up visit, particularly the first two years",
              "status": "completed_today",
              "detail": "IPSS 12, up from 7 before treatment; improving on tamsulosin",
              "observation_ids": [
                "OBS-IPSS-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Bowel function after radiotherapy",
              "cadence": "Every visit after radiotherapy",
              "status": "completed_today",
              "detail": "Softer stools once or twice a day with mild urgency, settling; no bleeding",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-III",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Bowel baseline missed before radiotherapy",
              "cadence": "Baseline before radiotherapy",
              "status": "deferred",
              "detail": "Not asked at the visit before radiotherapy, a deviation from the protocol. The wellness visit five weeks before that had recorded regular, formed stools once a day, and he confirms this today, so a baseline was available and no harm resulted. The bowel question is now on the pre-radiotherapy checklist",
              "guideline_ids": [
                "GL-AUA-ASTRO-PCA-2022-III",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Sexual function",
              "cadence": "Periodically after treatment",
              "status": "completed_today",
              "detail": "Reviewed; expected recovery after androgen deprivation explained; no treatment requested",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hot flashes and fatigue",
              "cadence": "Every visit until androgen deprivation effects resolve",
              "status": "completed_today",
              "detail": "Fewer hot flashes; fatigue from radiotherapy improving",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-2)",
              "cadence": "At intervals",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "observation_ids": [
                "OBS-PHQ2-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognition",
              "cadence": "Periodically after androgen deprivation",
              "status": "up_to_date",
              "detail": "Mini-Cog 5 of 5 at the wellness visit; no change reported",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Survivorship care plan and lifestyle",
              "cadence": "After treatment; lifestyle every visit",
              "status": "completed_today",
              "detail": "Written plan given; walking resumed; no tobacco",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACS-PCA-SURV-2014"
              ]
            }
          ],
          "follow_up": "Primary care in three months to review tamsulosin and urinary and bowel symptoms. PSA and testosterone in six months. Radiation oncology review in six weeks, three months after treatment. Influenza vaccine given today",
          "guideline_ids": [
            "GL-NCCN-PROSTATE-2026",
            "GL-AUA-ASTRO-PCA-2022-III",
            "GL-ACS-PCA-SURV-2014",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Subsequent annual wellness visit",
        "status": "finished",
        "date": "2026-06-09",
        "visit_type": "annual_wellness_subsequent",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "281038008",
          "display": "Geriatric annual health check",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Subsequent annual wellness visit; no new complaints",
          "billing_note": "HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day",
          "hpi": {
            "narrative": "Mr. Mandela is an 82-year-old man with unfavorable intermediate-risk prostate cancer, seven weeks after his first leuprolide injection, who is due to start radiotherapy in about six weeks. He returns for his subsequent annual wellness visit and completed the health risk assessment beforehand. He finished four weeks of bicalutamide without trouble. Since the injection he has had mild hot flashes, three or four a week, which wake him about once a week; his energy is a little lower in the afternoons, but he still walks every morning. His mood is good and he notices no change in memory or concentration. He has had no breast tenderness, chest pain, breathlessness, or leg swelling. Urinary symptoms are unchanged and mild. He takes vitamin D daily. He has had no falls, emergency visits, or hospital stays in the past year.",
            "elements": [
              {
                "label": "Visit",
                "value": "Subsequent annual wellness visit"
              },
              {
                "label": "Safety events",
                "value": "No falls, emergency visits, or hospital stays in the past year"
              },
              {
                "label": "Medicines",
                "value": "Leuprolide 22.5 mg every twelve weeks (second dose due in five weeks); cholecalciferol 1000 units daily; bicalutamide finished four weeks ago"
              },
              {
                "label": "Active conditions",
                "value": "Prostate cancer, unfavorable intermediate risk, on androgen deprivation before radiotherapy; low bone mass at the femoral neck"
              },
              {
                "label": "Functional status",
                "value": "Independent in all activities and instrumental activities of daily living"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with his foundation and visitors; close family and friends; no loneliness or low mood"
            },
            {
              "domain": "Tobacco",
              "finding": "Never used tobacco"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "No alcohol (AUDIT-C 0); no other drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 30 to 45 minutes most mornings; light resistance exercises twice a week added for bone health"
            },
            {
              "domain": "Nutrition",
              "finding": "Regular balanced meals; dairy and leafy greens for calcium; weight up 0.6 kg since starting androgen deprivation"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours a night; hot flashes wake him about once a week"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Independent; his assistant manages his calendar and he manages his own medicines"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors working; handrails on the stairs; good lighting"
            },
            {
              "domain": "Falls",
              "finding": "No falls this year; no fear of falling"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Some difficulty hearing in crowded rooms; wears glasses; eye examination five months ago"
            },
            {
              "domain": "Memory",
              "finding": "No concerns"
            },
            {
              "domain": "Pain",
              "finding": "Occasional knee stiffness in the morning"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Slightly lower energy in the afternoons on androgen deprivation; weight up 0.6 kg; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Some difficulty hearing in noisy rooms"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, breathlessness, or sputum"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels regular, about once a day, formed; no bleeding"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Mild urinary frequency, unchanged; no blood in the urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Mild morning knee stiffness; no bone pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No new skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, weakness, or numbness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0; no change in memory or concentration"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Mild hot flashes three or four times a week on androgen deprivation; no breast tenderness"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well, alert, and upright; weight 81.0 kg, BMI 24.2"
            },
            {
              "system": "Eyes",
              "finding": "Pupils equal and reactive; near vision 20/30 with glasses"
            },
            {
              "system": "Ears",
              "finding": "Canals clear; whispered-voice test missed on the left, passed on the right"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement; no lymph nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm at 68 per minute; no murmur; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Chest",
              "finding": "No gynecomastia or breast tenderness"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Mild crepitus in both knees without effusion; Timed Up and Go 10 seconds; rises from a chair without using his arms"
            },
            {
              "system": "Neurological",
              "finding": "Alert and oriented; gait steady; Mini-Cog 5 of 5"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic and engaged; judgment and insight intact"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions"
            }
          ],
          "assessment_plan": [
            {
              "display": "Subsequent annual wellness visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. Depression, alcohol, cognitive, and fall-risk screens are negative. He misses the whispered voice on the left. The lipid panel at the first visit showed total cholesterol 184, HDL 52, and LDL 112 mg/dL",
              "plan": [
                "Audiology for hearing testing",
                "Next annual wellness visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Prostate cancer, unfavorable intermediate risk, on androgen deprivation before radiotherapy",
              "assessment": "Planned treatment on track: radiotherapy begins in about six weeks, after fiducial markers are placed",
              "plan": [
                "Follow-up in five weeks with PSA, testosterone, and vitamin D, and the second leuprolide injection"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Androgen deprivation therapy",
              "assessment": "Mild hot flashes and slightly lower afternoon energy, both expected; no treatment wanted. Blood pressure 132/76 mm Hg. Mood and cognition normal",
              "plan": [
                "Keep walking and add light resistance exercise, which helps fatigue, muscle, and bone on androgen deprivation",
                "Layered clothing and a cool bedroom for hot flashes; medicines such as venlafaxine are available if they become troublesome"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 given today; no earlier pneumococcal vaccine on record; no further doses needed",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "Dose 1 given today; dose 2 due in two to six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "due",
              "detail": "High-dose vaccine when this season's supply arrives in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "due",
              "detail": "A single dose is recommended at 75 and older; at the pharmacy before the winter",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "Recommended at his age with this season's vaccine in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap seven years ago; next dose due in three years",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Screening from 76 to 85 is selective; discussed, and not recommended for him now, given his age and his current cancer treatment",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Bone density",
              "status": "up_to_date",
              "detail": "DXA eight weeks ago before androgen deprivation: femoral neck T-score -1.4, spine -0.6; repeat in one to two years",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Cholesterol and statin decision",
              "status": "completed_today",
              "detail": "Total cholesterol 184, HDL 52, LDL 112 mg/dL at the first visit; no diabetes or smoking. Risk calculators are not validated beyond 79, and evidence for starting a statin for primary prevention after 75 is limited; androgen deprivation adds some cardiometabolic risk. Not started after discussion; lipids and glucose again in one year on the androgen deprivation schedule",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C and HIV screening",
              "status": "not_indicated",
              "detail": "Outside the recommended age ranges and no risk factors",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 0",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Cognitive assessment",
              "status": "completed_today",
              "detail": "Mini-Cog 5 of 5"
            },
            {
              "service": "Falls prevention",
              "status": "completed_today",
              "detail": "Timed Up and Go 10 seconds; no falls; walking and resistance exercise continue",
              "guideline_ids": [
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "service": "Hearing",
              "status": "referred",
              "detail": "Whispered-voice test missed on the left; audiology arranged"
            },
            {
              "service": "Eye examination",
              "status": "up_to_date",
              "detail": "Five months ago"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being told the truth about his health, continuing his work for as long as he can, and making his own decisions. He chose not to record specific treatment preferences today. The plan will be revisited yearly and with any change in his health.",
          "follow_up": "Chronic-care follow-up in five weeks with the second leuprolide injection. Radiotherapy to start in about six weeks. Second zoster dose in two to six months. Audiology. Next annual wellness visit in one year",
          "guideline_ids": [
            "GL-AWV-CMS",
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic Medicare annual wellness visit; no synthetic illness episode is added under the recent-death rule.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 183,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 80.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-04-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 183,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 80.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-07-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 183,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 81.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-10-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 183,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 81.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from his lifetime was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-06-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 183,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 81.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the annual wellness visit, continuing the trend of the earlier visits.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:45:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Occupation: retired from public office; works with his foundation, speaks, and travels",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern occupation echoing the historical career; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Never smoker; no alcohol use reported; walks every morning",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives in his own home with family; independent; has a driver",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern living situation; no family member is named or used as a source of history.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Supports: family, close friends, and a personal assistant who manages his schedule",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths and supports.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities and instrumental activities of daily living",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "FUNC-002",
        "display": "Walks 30 to 45 minutes most mornings",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity level.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, warm, and composed; asks direct questions and wants to weigh the treatment options himself",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood good; PHQ-9 minimal at the first visit",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Man of 82 with newly diagnosed prostate adenocarcinoma, Grade Group 3, PSA 6.4 ng/mL, cT1c, NCCN unfavorable intermediate risk, found after a rising PSA on monitoring. Please advise on curative treatment, including radiotherapy with short-term androgen deprivation, and whether observation is reasonable at his age",
        "urgency": "Routine, within four to six weeks",
        "pertinent_history": "Fit and independent; walks every morning. Decades ago he had an operation that removed part of the prostate for benign enlargement with urinary blockage. Treated tuberculosis in the past, with no symptoms since. A rise in PSA on routine monitoring led to a multiparametric MRI (28 mL gland with a resection defect; 9 mm PI-RADS 4 lesion in the left peripheral zone; no extraprostatic extension) and an MRI-ultrasound fusion transperineal biopsy: Gleason 4+3 in 1 of 2 targeted cores (30 percent) and Gleason 3+4 in 2 of 12 systematic cores; 3 of 14 cores positive. Digital rectal examination: smooth, no nodule. PSA 6.4 ng/mL, testosterone 412 ng/dL, hemoglobin 14.1 g/dL, eGFR 69, alkaline phosphatase 74 U/L, A1c 5.5 percent, LDL 112 mg/dL, 25-hydroxyvitamin D 26 ng/mL. IPSS 7. PHQ-9 score 4. No regular medicines. PSMA PET/CT ordered; DXA booked for the day of the consultation",
        "questions": [
          "Do you agree with the risk group, and is staging complete with the PSMA PET/CT?",
          "What are his curative options at 82, and is observation a reasonable choice?",
          "If radiotherapy is chosen, should androgen deprivation be added, for how long, and how should it start?",
          "Does his earlier prostate operation change the choice of technique or his risk of urinary side effects?",
          "What monitoring is needed during and after treatment, including PSA follow-up, and which parts should primary care manage?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Mandela is seen at the request of Dr. Mokoena for newly diagnosed prostate cancer. A rise in PSA on routine monitoring led to an MRI and a targeted biopsy, which showed Grade Group 3 adenocarcinoma in 3 of 14 cores. He has mild urinary frequency, with an IPSS of 7, and no bone pain, weight loss, or blood in the urine. Decades ago part of his prostate was removed for benign enlargement. He had tuberculosis in the past, treated, with no symptoms since. He is independent, walks every morning, and keeps a full schedule of work and travel. He wants to understand all the options before deciding",
        "data_reviewed": "MRI prostate report and images, biopsy pathology, the first-visit PSA, testosterone, blood count, chemistry, A1c, lipids, and 25-hydroxyvitamin D, the PSMA PET/CT from two weeks ago (uptake confined to the left peripheral zone; no nodal, bone, or visceral disease), and the DXA scan from this morning (femoral neck T-score -1.4, lumbar spine -0.6)",
        "exam": [
          {
            "system": "General",
            "finding": "Well"
          },
          {
            "system": "Abdomen",
            "finding": "Soft; bladder not palpable"
          },
          {
            "system": "Musculoskeletal",
            "finding": "No spinal tenderness"
          },
          {
            "system": "Lymph nodes",
            "finding": "No inguinal or supraclavicular nodes"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Prostate adenocarcinoma, cT1c N0 M0, Grade Group 3, PSA 6.4 ng/mL, NCCN unfavorable intermediate risk",
            "assessment": "I agree with the risk group: Grade Group 3 alone places him in the unfavorable intermediate group. The PSMA PET/CT shows no nodal or distant disease, so staging is complete. He is fit, and his life expectancy is estimated at about ten years, so curative treatment is reasonable. Observation, with treatment only if symptoms develop, is also a reasonable choice at his age and was discussed. Active surveillance is not recommended for Grade Group 3 disease. Radical prostatectomy is not advised at his age and after his earlier prostate operation, which raises the risk of incontinence. Brachytherapy is not advised because of the resection defect. The recommended option is external beam radiotherapy to the prostate with four to six months of androgen deprivation"
          },
          {
            "problem_id": "PRB-003",
            "display": "Short-term androgen deprivation with radiotherapy",
            "assessment": "In unfavorable intermediate-risk disease, adding four to six months of androgen deprivation to radiotherapy improves cancer control. Starting it about three months before radiotherapy also shrinks the gland. A GnRH agonist with an anti-androgen for the first weeks blocks the testosterone flare. The main effects to monitor are hot flashes, fatigue, sexual effects, weight gain, bone loss, metabolic and cardiovascular risk, and changes in mood or memory"
          },
          {
            "display": "Earlier prostate operation and urinary function",
            "assessment": "The resection defect does not prevent external beam radiotherapy, but it slightly raises the risk of urinary irritation and, rarely, of a urethral stricture. Mild baseline symptoms (IPSS 7) are favorable. Moderate hypofractionation (60 Gy in 20 fractions or 70 Gy in 28) and conventional fractionation (74 to 80 Gy in 2 Gy fractions) give similar cancer control; after discussion of the shorter course and the lower dose per fraction, conventional fractionation of 74 Gy in 37 fractions was chosen"
          },
          {
            "display": "Bone health before androgen deprivation",
            "assessment": "Low bone mass at the femoral neck with mild vitamin D insufficiency. Ten-year hip fracture risk is below 3 percent, so no bone drug is needed for a six-month course"
          }
        ],
        "recommendations": [
          "External beam radiotherapy to the prostate and proximal seminal vesicles, 74 Gy in 37 daily fractions with intensity modulation and daily image guidance on fiducial markers; no pelvic nodal radiation",
          "Androgen deprivation for six months: bicalutamide 50 mg daily for four weeks starting today, leuprolide 22.5 mg intramuscularly in one week at this clinic and a second dose twelve weeks later, with radiotherapy starting about three months after the first injection",
          "Fiducial markers and planning CT and MRI about two weeks before radiotherapy",
          "During androgen deprivation: testosterone and PSA at three months, blood pressure and weight at every visit, hot flashes, fatigue, mood, and cognition reviewed at each visit, and glucose and lipids yearly",
          "Bone health: vitamin D 1000 units daily with a recheck in three months, calcium from food, resistance exercise, and DXA every one to two years",
          "During radiotherapy: weekly review for urinary and bowel effects; tamsulosin if urinary frequency or a weak stream develops; report blood in the urine or stool",
          "After radiotherapy: PSA six weeks after treatment, then every six months for five years and yearly after that; recurrence is a PSA rise of 2 ng/mL above the nadir (Phoenix); a temporary PSA bounce is not recurrence"
        ],
        "communication": "Discussed with Dr. Mokoena today. The patient chose radiotherapy with six months of androgen deprivation after hearing each option, including observation, and agrees with the plan",
        "follow_up": "Leuprolide injection here in one week. Fiducial markers and planning in about twelve weeks. Weekly review during radiotherapy, then radiation oncology three months after treatment and every six months. Primary care manages the androgen deprivation monitoring, bone health, blood pressure, distress screening, and PSA surveillance between reviews"
      },
      "guideline_ids": [
        "GL-AUA-ASTRO-PCA-2022-I",
        "GL-AUA-ASTRO-PCA-2022-III",
        "GL-NCCN-PROSTATE-2026",
        "GL-CMID-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Wants to understand a new diagnosis of prostate cancer after a rising PSA, and what treatment would mean at his age and with his commitments",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting concern.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "Wants to keep his travel and public work going during treatment",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic concern.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Reach an informed, shared decision on treatment after hearing every reasonable option, including observation",
        "status": "completed",
        "target_date": "2026-04-14",
        "outcome": "Radiotherapy with six months of androgen deprivation chosen at the radiation oncology consultation",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic decision goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Complete six months of androgen deprivation and the course of radiotherapy with side effects managed",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "Two leuprolide depots and 37 fractions completed; testosterone castrate on treatment; mild hot flashes and urinary frequency, managed",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Protect bone health on androgen deprivation: baseline DXA, vitamin D of 30 ng/mL or more, dietary calcium, and weight-bearing exercise",
        "status": "completed",
        "target_date": "2026-07-14",
        "outcome": "Femoral neck T-score -1.4; vitamin D 34 ng/mL on supplementation; walking daily",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic bone-health goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "PSA falling after radiotherapy, with a written surveillance plan",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "PSA 0.4 ng/mL six weeks after radiotherapy; PSA every six months planned",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surveillance goal; the nadir comes later.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Radiation oncology consultation to review staging and discuss curative treatment options and short-term androgen deprivation",
        "status": "completed",
        "guideline_ids": [
          "GL-AUA-ASTRO-PCA-2022-I",
          "GL-NCCN-PROSTATE-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Staging for unfavorable intermediate-risk disease with PSMA PET/CT",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-PROSTATE-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic staging plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Treatment chosen through shared decision-making: image-guided external beam radiotherapy to the prostate with six months of androgen deprivation (leuprolide, with bicalutamide for the first four weeks)",
        "status": "completed",
        "recorded_date": "2026-04-14",
        "guideline_ids": [
          "GL-AUA-ASTRO-PCA-2022-I",
          "GL-AUA-ASTRO-PCA-2022-III",
          "GL-NCCN-PROSTATE-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Androgen deprivation monitoring: testosterone, PSA, blood pressure, glucose and lipids, DXA at baseline and every one to two years, vitamin D and calcium, hot flashes, mood, and cognition",
        "status": "completed",
        "recorded_date": "2026-04-14",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-ACS-PCA-SURV-2014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic monitoring on the CMID prostate cancer schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "After radiotherapy: PSA every six months for five years, then yearly, with recurrence defined as a rise of 2 ng/mL above the nadir (Phoenix); urinary and bowel symptoms at every visit",
        "status": "completed",
        "recorded_date": "2026-04-14",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-NCCN-PROSTATE-2026",
          "GL-ACS-PCA-SURV-2014"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surveillance plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Distress screening at each visit, physical activity, and a written survivorship care plan",
        "status": "completed",
        "guideline_ids": [
          "GL-ACS-PCA-SURV-2014",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic survivorship plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T22:30:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-PROSTATE-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AUA-ASTRO-PCA-2022-I",
        "title": "Eastham JA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol 2022;208(1):10-18",
        "publisher": "American Urological Association and American Society for Radiation Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35536144/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-AUA-ASTRO-PCA-2022-III",
        "title": "Eastham JA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part III: Principles of Radiation and Future Directions. J Urol 2022;208(1):26-33",
        "publisher": "American Urological Association and American Society for Radiation Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35536141/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ACS-PCA-SURV-2014",
        "title": "Skolarus TA, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 2014;64(4):225-249",
        "publisher": "American Cancer Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/24916760/",
        "version_or_year": "2014"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, prostate cancer monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AWV-CMS",
        "title": "Medicare Wellness Visits (Medicare Learning Network)",
        "publisher": "Centers for Medicare & Medicaid Services",
        "url": "https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-FALLS-2024",
        "title": "Falls Prevention in Community-Dwelling Older Adults: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the risk grouping, the choice of six months of androgen deprivation and conventional fractionation at 82, and the androgen deprivation monitoring."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what his doctors, his spokeswoman, his office, and he himself made public, with basic biographical facts from the Nelson Mandela Foundation. No statement or health fact is attributed to a relative or colleague."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Imprisonment and tuberculosis are recorded as history only, factually; no behavioral-health diagnosis; death recorded without detail."
    }
  }
}
